subject expert committee

SEC Recommends Phase 1 Clinical Trials Of Reliance’s 2-Dose Covid-19 Vaccine

The Subject Expert Committee (SEC) has recommended phase 1 clinical trials of Reliance Life Sciences’ vaccine candidate against the COVID-19 disease Reported a news agency ANI on Friday. According to…

View Post

Key Expert Panel Meet Today To Review COVID-19 Vaccine Emergency-Use Application

Emergency usage approval applications for coronavirus vaccines submitted by the Serum Institute of India, Bharat Biotech, and Pfizer will be taken up again today by a panel of experts appointed…

View Post

Oxford Covid-19 Vaccine ‘Covishield’ Likely To Be First To Get Approval In India

With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford Covid-19 vaccine…

View Post

Serum Institute Submits Data For Emergency Approval Of Covishield

The Serum Institute of India (SII) has submitted additional data required by the Drug Controller General of India (DCGI) for determining the safety and immunogenicity of its Covid-19 vaccine candidate,…

View Post

When Will India Get Vaccine? Take A Look At India’s Preparation For Coronavirus Vaccine

Keeping in mind all the potential risks involved with the Covid vaccination, and the safety and the health of people, the Central Drugs Standard Control Organisation’s Subject Expert Committee has…

View Post

Applications Of Bharat Biotech, Pfizer, Serum Institute’s Vaccine To Be Reviewed Today: Here’s What Might Happen Next

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) will meet on Wednesday to review applications of Pfizer, Serum Institute of India, and Bharat Biotech seeking emergency use…

View Post

Menu

subject expert committee

SEC Recommends Phase 1 Clinical Trials Of Reliance’s 2-Dose Covid-19 Vaccine

Key Expert Panel Meet Today To Review COVID-19 Vaccine Emergency-Use Application

Oxford Covid-19 Vaccine ‘Covishield’ Likely To Be First To Get Approval In India

Serum Institute Submits Data For Emergency Approval Of Covishield

When Will India Get Vaccine? Take A Look At India’s Preparation For Coronavirus Vaccine

Applications Of Bharat Biotech, Pfizer, Serum Institute’s Vaccine To Be Reviewed Today: Here’s What Might Happen Next

Chilli Peppers May Potentially Fight Mesothelioma Cancer-Cells: Study Reveals

No MBBS Admissions Without Annual Declaration: NMC’s New Directive

High Court Slams Doctors for Prioritizing Private Practice Over Public Healthcare

National Cancer Awareness Day 2024: Fatigue, Unexplained Weight Loss, 6 Early Warning Signs of Cancer

Delhi AQI Today: Does Inhaling Toxic Smog Increases Heart Attack Risk?

Hearing Loss Is an Independent Risk Factor for Parkinson’s Disease: Jama Study Reveals

Breastfeeding Linked to Lower Rates of Postpartum Depression: Study Finds

Consuming High Levels of Omega-3, Omega-6 May Keep Cancer at Bay: Study Reveals